{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:21:41Z","timestamp":1784334101712,"version":"3.55.0"},"reference-count":37,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014969","name":"Guilin Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014969","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Australian Government Research Training Program (RTP) scholarship"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Chronic tympanic membrane perforations (TMP) pose a significant clinical challenge, but basic fibroblast growth factor (FGF-2) shows promise for their treatment, despite its instability in aqueous solutions which hampers the sustained delivery crucial for the healing process. Addressing this, our research focused on the development of stabilized FGF-2 formulations, F5 and F6, incorporating dual, generally regarded as safe (GRAS) excipients to enhance stability and therapeutic efficacy. F5 combined FGF-2 (1600 ng\/mL) with 0.05% w\/v methylcellulose (MC) and 20 mM alanine, while F6 used FGF-2 with 0.05% w\/v MC and 1 mg\/mL human serum albumin (HSA). Our findings demonstrate that these novel formulations not only significantly improve the cytoproliferation of human dermal fibroblasts but also exhibit the most potent chemoattractant effects, leading to the highest fibroblast monolayer closure rates (92.5% for F5 and 94.1% for F6 within 24 h) compared to other FGF-2 solutions tested. The comparable performance of F5 and F6 underscores their potential as innovative, less invasive, and cost-effective options for developing otic medicinal products aimed at the effective treatment of chronic TMP.<\/jats:p>","DOI":"10.3390\/ph17020247","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T06:59:26Z","timestamp":1707893966000},"page":"247","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In Vitro Assessment of Wound-Healing Efficacy of Stabilized Basic Fibroblast Growth Factor (FGF-2) Solutions"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2459-315X","authenticated-orcid":false,"given":"Leah","family":"Benington","sequence":"first","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, University of Western Australia, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Mo","sequence":"additional","affiliation":[{"name":"Neuroscience Laboratory, The Affiliated Hospital of Guilin Medical University, Guilin 541001, China"},{"name":"Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Li","sequence":"additional","affiliation":[{"name":"Neuroscience Laboratory, The Affiliated Hospital of Guilin Medical University, Guilin 541001, China"},{"name":"Department of Pharmacy, Tangshan Central Hospital, Tangshan 063000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7413-1623","authenticated-orcid":false,"given":"Gunesh","family":"Rajan","sequence":"additional","affiliation":[{"name":"Otolaryngology, Head & Neck Surgery, Division of Surgery, Medical School, University of Western Australia, Perth, WA 6009, Australia"},{"name":"Department of Otolaryngology, Head & Neck Surgery, Luzerner Kantonsspital, 6000 Luzern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8773-3036","authenticated-orcid":false,"given":"Cornelia","family":"Locher","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, University of Western Australia, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7307-0742","authenticated-orcid":false,"given":"Lee Yong","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, University of Western Australia, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/coa.12164","article-title":"Epithelial pearl formation following tympanic membrane regeneration therapy using an atelocollagen\/silicone membrane and basic fibroblast growth factor: Our experience from a retrospective study of one hundred sixteen patients","volume":"38","author":"Hakuba","year":"2013","journal-title":"Clin. Otolaryngol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0030-6665(20)30467-9","article-title":"Tympanic membrane wound healing. An overview","volume":"28","author":"Gladstone","year":"1995","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"ref_3","first-page":"S60","article-title":"Complications of otitis media in Indigenous and non-Indigenous children","volume":"191","author":"Perry","year":"2009","journal-title":"Med. J. Aust."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/coa.12017","article-title":"Impact of basic fibroblast growth factor on healing of tympanic membrane perforations due to direct penetrating trauma: A prospective non-blinded\/controlled study","volume":"37","author":"Zhang","year":"2012","journal-title":"Clin. Otolaryngol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MAO.0000000000000767","article-title":"Tympanoplasty for chronic tympanic membrane perforation in children: Systematic review and meta-analysis","volume":"36","author":"Hardman","year":"2015","journal-title":"Otol. Neurotol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amjoto.2011.07.006","article-title":"Analysis of the effectiveness of basic fibroblast growth factor treatment on traumatic perforation of the tympanic membrane at different time points","volume":"33","author":"Lou","year":"2012","journal-title":"Am. J. Otolaryngol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijporl.2011.03.015","article-title":"Pediatric myringoplasty: A study of factors affecting outcome","volume":"75","author":"Knapik","year":"2011","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000265121","article-title":"Expression of fibroblast growth factor receptors 1\u20134 in human chronic tympanic membrane perforation","volume":"71","author":"Kakigi","year":"2009","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/000348949009900114","article-title":"Epidermal growth factor binding and action on tympanic membranes","volume":"99","author":"Petitjean","year":"1990","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/000348949510401008","article-title":"Immunohistochemical study of transforming growth factor-\u03b1 expression in normal and perforated tympanic membrane","volume":"104","author":"Koba","year":"1995","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0196-0709(94)90133-3","article-title":"Effect of basic fibroblast growth factor on normal tympanic membrane","volume":"15","author":"Mondain","year":"1994","journal-title":"Am. J. Otolaryngol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/0016-5085(94)90017-5","article-title":"Fibroblast growth factors modulate intestinal epithelial cell growth and migration","volume":"106","author":"Dignass","year":"1994","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1073\/pnas.95.3.1218","article-title":"Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice","volume":"95","author":"Holland","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.2337\/diabetes.53.12.3097","article-title":"Fibroblast growth factor 1: A key regulator of human adipogenesis","volume":"53","author":"Hutley","year":"2004","journal-title":"Diabetes"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Farooq, M., Khan, A.W., Kim, M.S., and Choi, S. (2021). The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration. Cells, 10.","DOI":"10.3390\/cells10113242"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Prudovsky, I. (2021). Cellular Mechanisms of FGF-Stimulated Tissue Repair. Cells, 10.","DOI":"10.3390\/cells10071830"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/lio2.395","article-title":"Topical fibroblast growth factor-2 for treatment of chronic tympanic membrane perforations","volume":"5","author":"Santos","year":"2020","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/08977194.2014.980905","article-title":"Evaluation of the optimum time for direct application of fibroblast growth factor to human traumatic tympanic membrane perforations","volume":"33","author":"Lou","year":"2015","journal-title":"Growth Factors"},{"key":"ref_19","first-page":"1","article-title":"Trauma of the middle ear. Clinical findings, postmortem observations and results of experimental studies","volume":"35","author":"Strohm","year":"1986","journal-title":"Adv. Otorhinolaryngol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/stem.1021","article-title":"Thermal stability of fibroblast growth factor protein is a determinant factor in regulating self-renewal, differentiation, and reprogramming in human pluripotent stem cells","volume":"30","author":"Chen","year":"2012","journal-title":"Stem Cells"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Koledova, Z., Sumbal, J., Rabata, A., de La Bourdonnaye, G., Chaloupkova, R., Hrdlickova, B., Damborsky, J., and Stepankova, V. (2019). Fibroblast Growth Factor 2 Protein Stability Provides Decreased Dependence on Heparin for Induction of FGFR Signaling and Alters ERK Signaling Dynamics. Front. Cell Dev. Biol., 7.","DOI":"10.3389\/fcell.2019.00331"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/MAO.0b013e31822e0e53","article-title":"Regenerative treatment for tympanic membrane perforation","volume":"32","author":"Kanemaru","year":"2011","journal-title":"Otol. Neurotol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijporl.2014.12.014","article-title":"A pilot study investigating basic fibroblast growth factor for the repair of chronic tympanic membrane perforations in pediatric patients","volume":"79","author":"Acharya","year":"2015","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00005537-200308000-00016","article-title":"A new method for closing tympanic membrane perforations using basic fibroblast growth factor","volume":"113","author":"Hakuba","year":"2003","journal-title":"Laryngoscope"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/08977194.2014.952411","article-title":"Effects of basic fibroblast growth factor dose on traumatic tympanic membrane perforation","volume":"32","author":"Lou","year":"2014","journal-title":"Growth Factors"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/08977194.2015.1122003","article-title":"Risk factors affecting human traumatic tympanic membrane perforation regeneration therapy using fibroblast growth factor-2","volume":"33","author":"Lou","year":"2015","journal-title":"Growth Factors"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.14639\/0392-100X-1480","article-title":"The short- and long-term adverse effects of FGF-2 on tympanic membrane perforations","volume":"38","author":"Lou","year":"2018","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Benington, L.R., Rajan, G., Locher, C., and Lim, L.Y. (2021). Stabilisation of Recombinant Human Basic Fibroblast Growth Factor (FGF-2) against Stressors Encountered in Medicinal Product Processing and Evaluation. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111762"},{"key":"ref_29","unstructured":"Shah, D. (1998). Effect of Various Additives on the Stability of Basic Fibroblast Growth Factor and Development of an Intradermal Injectable Formulation, University of Missouri."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/1056-8719(92)90059-A","article-title":"Quantitative colorimetric assay for basic fibroblast growth factor using bovine endothelial cells and heparin","volume":"28","author":"Tomoko","year":"1992","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bit.260110205","article-title":"Methylcellulose effect on cell proliferation and glucose utilization in chemically defined medium in large stationary cultures","volume":"11","author":"Bryant","year":"1969","journal-title":"Biotechnol. Bioeng."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0171-2985(11)80487-0","article-title":"Effect of L-alanine and some other amino acids on thymocyte proliferation in vivo","volume":"188","author":"Hagglund","year":"1993","journal-title":"Immunobiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10616-010-9263-3","article-title":"Albumin and mammalian cell culture: Implications for biotechnology applications","volume":"62","author":"Francis","year":"2010","journal-title":"Cytotechnology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3892\/ijo_00000448","article-title":"Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity","volume":"35","author":"Kanda","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0022-3476(88)80271-3","article-title":"Adenosine deaminase deficiency with late onset of recurrent infections: Response to treatment with polyethylene glycol-modified adenosine deaminase","volume":"113","author":"Levy","year":"1988","journal-title":"J. Pediatr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/polc.5070510111","article-title":"Structure and properties of pharmacologically active polymers","volume":"51","author":"Ringsdorf","year":"1975","journal-title":"J. Polym. Sci. Polym. Symp."},{"key":"ref_37","first-page":"15","article-title":"Boyden chamber assay","volume":"294","author":"Chen","year":"2005","journal-title":"Methods Mol. Biol."}],"updated-by":[{"DOI":"10.3390\/ph17070892","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000}}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/2\/247\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T14:42:58Z","timestamp":1754232178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/2\/247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["ph17020247"],"URL":"https:\/\/doi.org\/10.3390\/ph17020247","relation":{"correction":[{"id-type":"doi","id":"10.3390\/ph17070892","asserted-by":"object"}]},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]}}}